WY
54
-11
MRK
58
2
VZ
45
-24
FFIV
45
-6
PCG
70
-10
PHM
46
-18
LH
43
-5
MPC
39
-2
ED
45
3
PH
60
-15
SCHW
56
-19
EFX
50
-2
TRIP
52
-29
PM
49
-25
XRX
41
-18
SYF
69
-14
HD
34
3
PSX
39
-13
NRG
37
-13
NKE
40
-3
WY
54
-11
MRK
58
2
VZ
45
-24
FFIV
45
-6
PCG
70
-10
PHM
46
-18
LH
43
-5
MPC
39
-2
ED
45
3
PH
60
-15
SCHW
56
-19
EFX
50
-2
TRIP
52
-29
PM
49
-25
XRX
41
-18
SYF
69
-14
HD
34
3
PSX
39
-13
NRG
37
-13
NKE
40
-3
Financhill
Back

RosCan Gold Corp. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
29

RCGCF
RosCan Gold Corp.

Last Price:
$0.09
Seasonality Move:
-1.85%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.30
Seasonality Move:
11.35%
Sell
29
RosCan Gold Corp. (RCGCF) is a Sell

Is RosCan Gold Corp. a Buy, Sell or Hold?

  • The current RosCan Gold Corp. [RCGCF] share price is $0.09. The Score for RCGCF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • RCGCF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.31. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCGCF Stock Price Chart

What is RosCan Gold Corp.'s stock price today?

  • The RosCan Gold Corp. share price today is $0.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCGCF is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCGCF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 49.27 Sell
Chaikin Money Flow: -104428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.07 - 0.09) Buy
Bollinger Bands (100): (0.06 - 0.1) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 17.9 Buy
Relative Strength Index (14 RSI): 84.85 Buy
Chaikin Money Flow: 566238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (179.97 - 241.41) Buy
Bollinger Bands (100): (53.79 - 174.17) Buy

RCGCF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.09 Sell
20-day SMA: 0.09 Sell
50-day SMA: 0.08 Buy
200-day SMA: 0.06 Buy
8-day EMA: 0.02 Buy
20-day EMA: 0.01 Buy
50-day EMA: 0 Buy
200-day EMA: 0 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.16 Buy
20-day SMA: 220.01 Buy
50-day SMA: 157.24 Buy
200-day SMA: 71.79 Buy
8-day EMA: 219.83 Buy
20-day EMA: 208.3 Buy
50-day EMA: 169.39 Buy
200-day EMA: 91.98 Buy

RosCan Gold Corp. Earnings Growth & RCGCF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

RosCan Gold Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):